The rapid growth of prescription drug expenditures is a major problem in South Korea. Accordingly, the South Korean government introduced a positive listing system in 2006.
They also adopted various price reduction policies. Nevertheless, the total expenditure for lipid-lowering drugs have…
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea
No comments:
Post a Comment